System pH-Sensitive mPEG-Hz-Cholesterol Conjugates as a Liposome Delivery
暂无分享,去创建一个
[1] J. Desbrières,et al. Hydrogels Based on Carboxymethylcellulose and Gelatin for Inclusion and Release of Chloramphenicol , 2009 .
[2] F. Veronese,et al. A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery , 2009 .
[3] K. Uhrich,et al. Amphiphilic Scorpion-like Macromolecules as Micellar Nanocarriers , 2008 .
[4] Eugene Lih,et al. An In Situ Gel-Forming Heparin-Conjugated PLGA-PEG-PLGA Copolymer , 2008 .
[5] Zengjuan Zheng,et al. Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles. , 2008, Colloids and surfaces. B, Biointerfaces.
[6] Q. Guo,et al. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. , 2008, Biomaterials.
[7] Dipak K. Sarker,et al. Effects of poly (ethylene glycol) chains conformational transition on the properties of mixed DMPC/DMPE-PEG thin liquid films and monolayers. , 2007, Colloids and surfaces. B, Biointerfaces.
[8] Dae-Duk Kim,et al. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[9] L. Yu,et al. Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives. , 2007, Colloids and surfaces. B, Biointerfaces.
[10] V. Torchilin,et al. “Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes , 2007, Journal of liposome research.
[11] Z. Zhou,et al. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. , 2005, International journal of pharmaceutics.
[12] D. Thompson,et al. Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[13] D. Aggarwal,et al. Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.
[14] T. Allen,et al. Targeting Stealth liposomes in a murine model of human small cell lung cancer. , 2001, Biochimica et biophysica acta.
[15] J Verweij,et al. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.
[16] R. Panchagnula. Pharmaceutical aspects of paclitaxel , 1998 .
[17] R. Straubinger,et al. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia. , 1996, Cancer letters.
[18] A. Gabizon,et al. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. , 1991, Biochimica et biophysica acta.
[19] J. Zhang,et al. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.